Apollo Strategic Growth Capital announced the pricing of its $750 million IPO tonight and the units are expected to begin trading on the NYSE under the symbol “APSG.U” tomorrow, Friday, October 2nd.
This new company aims to combine with a company that is leading an industry with secular tailwinds and multiple avenues to growth. Apollo Strategic Growth is led by CEO and Director Sanjay Patel, CFO and Chief Accounting Officer James Crossen and Executive Chairman Scott Kleinman.
Total SPAC deal count for 2020 year-to-date is now 125 with $47.6 billion in gross proceeds raised. This offering is expected to close on Tuesday, October 6 .
Citigroup Global Markets Inc. is acting as joint bookrunner and representative of the underwriters and Credit Suisse Securities (USA) LLC and Goldman Sachs & Co. LLC are acting as joint bookrunners. Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...